CD274 and neoplasm: In the context of breast cancer, surrounding adipocytes promote neoplastic cell resistance to the anti-human epidermal growth factor receptor 2 protein antibody Trastuzumab (3), and expression of programmed cell death-ligand 1 (PD-L1) in mammary adipocytes attenuates anti-tumor immunity (6).